Patents by Inventor Stan Dysart

Stan Dysart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of hip pain with sustained-release liposomal anesthetic compositions
    Patent number: 11918688
    Abstract: In some embodiments provided herein is a method of treating hip pain in a subject, the method comprising administering into the subject a pharmaceutical composition comprising: a) a multivesicular liposome comprising: at least one amphipathic lipid, and at least one neutral lipid; and b) an aqueous phase comprising bupivacaine phosphate, wherein the aqueous phase is encapsulated within the multivesicular liposome.
    Type: Grant
    Filed: January 10, 2022
    Date of Patent: March 5, 2024
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Jonathan H. Slonin, Roy Winston, Stan Dysart
  • Treatment of hip pain with sustained-release liposomal anesthetic compositions
    Patent number: 11819573
    Abstract: In some embodiments provided herein is a method of treating hip pain in a subject, the method comprising administering into the subject a pharmaceutical composition comprising: a) a multivesicular liposome comprising: at least one amphipathic lipid, and at least one neutral lipid; and b) an aqueous phase comprising bupivacaine phosphate, wherein the aqueous phase is encapsulated within the multivesicular liposome.
    Type: Grant
    Filed: March 2, 2022
    Date of Patent: November 21, 2023
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Jonathan H. Slonin, Roy Winston, Stan Dysart
  • Treatment of hip pain with sustained-release liposomal anesthetic compositions
    Patent number: 11813357
    Abstract: In some embodiments provided herein is a method of treating hip pain in a subject, the method comprising administering into the subject a pharmaceutical composition comprising: a) a multivesicular liposome comprising: at least one amphipathic lipid, and at least one neutral lipid; and b) an aqueous phase comprising bupivacaine phosphate, wherein the aqueous phase is encapsulated within the multivesicular liposome.
    Type: Grant
    Filed: May 17, 2022
    Date of Patent: November 14, 2023
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Jonathan H. Slonin, Roy Winston, Stan Dysart
  • TREATMENT OF HIP PAIN WITH SUSTAINED-RELEASE LIPOSOMAL ANESTHETIC COMPOSITIONS
    Publication number: 20220273564
    Abstract: In some embodiments provided herein is a method of treating hip pain in a subject, the method comprising administering into the subject a pharmaceutical composition comprising: a) a multivesicular liposome comprising: at least one amphipathic lipid, and at least one neutral lipid; and b) an aqueous phase comprising bupivacaine phosphate, wherein the aqueous phase is encapsulated within the multivesicular liposome.
    Type: Application
    Filed: May 17, 2022
    Publication date: September 1, 2022
    Inventors: Jonathan H. Slonin, Roy Winston, Stan Dysart
  • TREATMENT OF HIP PAIN WITH SUSTAINED-RELEASE LIPOSOMAL ANESTHETIC COMPOSITIONS
    Publication number: 20220218613
    Abstract: In some embodiments provided herein is a method of treating hip pain in a subject, the method comprising administering into the subject a pharmaceutical composition comprising: a) a multivesicular liposome comprising: at least one amphipathic lipid, and at least one neutral lipid; and b) an aqueous phase comprising bupivacaine phosphate, wherein the aqueous phase is encapsulated within the multivesicular liposome.
    Type: Application
    Filed: March 2, 2022
    Publication date: July 14, 2022
    Inventors: Jonathan H. Slonin, Roy Winston, Stan Dysart
  • TREATMENT OF HIP PAIN WITH SUSTAINED-RELEASE LIPOSOMAL ANESTHETIC COMPOSITIONS
    Publication number: 20220218610
    Abstract: In some embodiments provided herein is a method of treating hip pain in a subject, the method comprising administering into the subject a pharmaceutical composition comprising: a) a multivesicular liposome comprising: at least one amphipathic lipid, and at least one neutral lipid; and b) an aqueous phase comprising bupivacaine phosphate, wherein the aqueous phase is encapsulated within the multivesicular liposome.
    Type: Application
    Filed: January 10, 2022
    Publication date: July 14, 2022
    Inventors: Jonathan H. Slonin, Roy Winston, Stan Dysart